So far, the Serum Institute has an agreement to supply 166 million doses to the Indian government, with another firm, Bharat Biotech, supplying 10 million doses. India also has licensing deals with the Russian Gamaleya Research Institute to produce 200 million doses of the Sputnik vaccine.
You need to
Log in and be a client to read this story in full and get access to audio and images.
